Nasal swabs were tested by reverse transcription polymerase chain reaction for RSV, SARS-CoV-2, and influenza. Case patients tested positive for RSV only, and control patients tested negative for ...

MSD has reported phase 2b/3 data with its clesrovimab antibody for respiratory syncytial virus (RSV) preventions in infants, which could be a challenger to Sanofi and AstraZeneca's fast-growing ...

Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance to generate revenue from a second product as sales of its Spikevax COVID-19 shot have slumped.